South African pharmaceutical firm iDexis is fighting back against local healthcare regulators over its Compounded GLP-1 Weight-Loss Injections. The company strongly defends its product safety amid serious compliance allegations. The dispute follows a joint statement by the South African Health Products Regulatory Authority (SAHPRA) and the South African Pharmacy Council (SAPC). The regulators ordered an immediate recall of the company’s…